Drugmakers to join forces to make millions of Ebola vaccine doses
LONDON (Reuters) - Leading drugmakers plan to work together to speed up the development of an Ebola vaccine and hope to produce millions of doses for use next year.
U.S. firm Johnson & Johnson said on Wednesday that it aims to produce at least 1 million doses of its two-step vaccine next year and has already discussed collaboration with Britain's GlaxoSmithKline, which is working on a rival vaccine.
The economics of an Ebola vaccine are still unclear but drug companies with an eye on their reputations are under pressure to respond to the major international health crisis now ravaging one of the poorest corners of Africa.
J&J's head of research Paul Stoffels said it was important to have several experimental vaccine candidates in development, since it is not clear which ones will work, but resources could in future be focused on one clear winner.
How great is this? Apparently, there's either profit in this medicine or our political leadership has more influence than I thought.
An effective vaccine is the only thing that will really put an end to this threat from reoccurring. Though, I am curious of the cost and coverage?